Diagnostics of Skeletal Metastases with Using SPECT/CT
https://doi.org/10.37174/2587-7593-2018-1-3-21-26
Abstract
Purpose: To define the diagnostic capabilities of SPECT/CT in comparison with whole body scintigraphy (WBS) in patients with bone metastases.
Material and methods: It was included 67 patients with bone metastases of breast cancer, prostate cancer and other tumors. The evaluation was included WBS and SPECT/CT.
Results: Аll patients were divided into 2 groups – those with single and multiple metastases. SPECT/CT showed higher efficiency in detecting bone metastases than WBS. The full detection of bone metastases with WBS ranged from 31 to 56 % compared to SPECT/CT for groups respectively. In some cases (for groups respectively: 4 to 9.5 % depending on the number of metastases and their localization) of WBS was not informative, recorded the absence of lesions.
Conclusion: SPECT/CT can improve the diagnosis of bone metastasis.
About the Authors
A. D. Ryzhkov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Moscow
Russian Federation
Moscow
A. S. Krylov
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Moscow
Russian Federation
Moscow
Y. A. Shchipakhina
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Moscow
Russian Federation
Moscow
N. V. Kochergina
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Moscow
Russian Federation
Moscow
D. A. Komanovskaya
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Moscow
Russian Federation
Moscow
M. E. Bilik
N.N. Blokhin National Medical Research Center of Oncology
Russian Federation
Moscow
Russian Federation
Moscow
References
1. Chakraborty D., Bhattacharya A., Mete U.K., Mittal B.R. Comparison of 18F fluoride PET/CT and 99mTc-MDP bone scan in the detection of skeletal metastases in urinary bladder carcinoma // Clin. Nucl. Med. 2013. Vol. 38. № 8. P. 616–621. DOI:10.1097/RLU.0b013e31828da5cc.
2. Qiu Z.L., Xue Y.L., Song H.J., Luo Q.Y. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer // Nucl. Med. Commun. 2012. Vol. 33. № 12. P. 1232–1242. DOI: 10.1097/MNM.0b013e328358d9c0.
3. Shen G., Deng H., Hu S., Jia Z. Comparison of choline-PET/CT, MRI, SPECT, and bone scintigraphy in the diagnosis of bone metastases in patients with prostate cancer: a meta-analysis // Skeletal Radiol. 2014. Vol. 43. № 11. P. 1503–1513. DOI: 10.1007/s00256-014-1903-9.
4. Shen C.T., Qiu Z.L., Han T.T., Luo Q.Y. Performance of 18F-fluoride PET or PET/CT for the detection of bone metastases: a metaanalysis // Clin. Nucl. Med. 2015. Vol. 40 № 2. P. 103–110. DOI: 10.1097/RLU.0000000000000592.
5. Buck A.K., Nekolla S., Ziegler S. et al. SPECT/CT // J. Nucl. Med. 2008. Vol. 49. № 8. P. 1305–1319. DOI: 10.2967/jnumed.107.050195.
6. Рыжков А.Д., Иванов С.М., Ширяев С.В. и соавт. ОФЭКТ/ КТ в контроле лучевого лечения костных метастазов остеосаркомы // Вопросы онкологии. 2016. Т. 62. № 5. С. 654–659.
7. Haraldsen A., Bluhme H., Rohl L. et al. Single photon emission computed tomography (SPECT) and SPECT/low dose computerized tomography did not increase sensitivity or specificity compared to planar bone scintigraphy for detection of bone metastases in advanced breast cancer // Clin. Physiol. Funct. Imaging. 2016. Vol. 36. № 1. P. 40–46. DOI: 10.1111/cpf.12191.
8. Palmedo H., Marx C., Ebert A. et al. Whole-body SPECT/CT for bone scintigraphy: diagnostic value and effect on patient management in oncological patients // Eur. J. Nucl. Med. Mol. Imaging. 2014. Vol. 41. № 1. P. 59–67. DOI: 10.1007/s00259-0132532-6.
9. Ahmadzadehfar H., Marx C., Ebert A. et al. Diagnostic accuracy of SPECT/CT in comparison to whole body scintigraphy and SPECT in patients with suspected osseous metastases: Results of a two center study // J. Nucl. Med. 2012. Vol. 53. Suppl. 1. P. 336.
10. Рыжков А.Д., Крылов А.С., Ширяев С.В. и соавт. Преимущество комбинированной ОФЭКТ/КТ в диагностике метастазов в костях // Мед. радиол. и радиац.безопасность. 2017. Т. 62. № 5. С. 33–38. DOI: 10.12737/article_59f2fc0812bc46.45377149.
11. Lofgren J., Mortensen J., Loft A. et al. Diagnosing bone metastases. Pilot data from a prospective study comparing [99mTc]-MDP planar bone scintigraphy, whole body SPECT/CT, [18F]-fluoride PET/CT and [18F]-fluoride PET/MRI // J. Nucl. Med. 2013. Vol. 54. № 2. P. 93–92.
12. Крживицкий П.И., Канаев С.В., Новиков С.Н. и соавт. ОФЭКТ/КТ в диагностике метастатического поражения скелета // Вопросы онкологии. 2014. Т. 60. № 1. С. 56–63.
13. Cuccurullo V., Cascini G.L., Tamburrini O. et al. Bone metastases radiopharmaceuticals: an overview // Curr. Radiopharm. 2013. № 6. P. 41–47.
14. Ginde A.A., Foianini A., Renner D.M. et al. Availability and quality of computed tomography and magnetic resonance imaging equipment in U.S. emergency departments // Аcad. Emerg. Med. 2008. Vol. 15. № 8. P. 780–783. DOI: 10.1111/j.15532712.2008.00192.x.
15. Gorska-Chrząstek M., Kovacevicz-Kuśmierek K., Chrząstek J. et al. Reliability of different radioisotopic techniques in diagnosing solitary hot spots in the spine of patients with malignant neoplasm // Pol. Arch. Med. Wewn. 2013. Vol. 123. № 7–8. P. 386–393.
16. Рыжков А.Д., Ширяев С.В., Оджарова А.А. и соавт. Остеосцинтиграфия метастазов в кости с фосфатными соединениями, меченными 99mTc // Мед. радиол. и радиац. безопасность. 2007. Т. 52. № 4. С. 62–68.
17. O’Sullivan G.J., Carty F.L., Cronin C.G. Imaging of bone metastasis: An update // World J. Radiol. 2015. Vol. 28. Suppl. 7. № 8. P. 202–211. DOI: 10.4329/wjr.v7.i8.202.
Review
For citations:
Ryzhkov A.D., Krylov A.S., Shchipakhina Y.A., Kochergina N.V., Komanovskaya D.A., Bilik M.E. Diagnostics of Skeletal Metastases with Using SPECT/CT. Journal of oncology: diagnostic radiology and radiotherapy. 2018;1(3):21-26. (In Russ.) https://doi.org/10.37174/2587-7593-2018-1-3-21-26
Views:
667
Email this article 